Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Download references

Open Access Highly Accessed Open Badges

Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)

Roman Hájek*, Richard Bryce, Sunhee Ro, Barbara Klencke and Heinz Ludwig

BMC Cancer 2012, 12:415  doi:10.1186/1471-2407-12-415